9/19/2007

The FDA has approved St. Jude Medical's Promote cardiac resynchronization therapy defibrillator and Current implantable cardioverter defibrillator. The products, which will be unveiled at a heart association meeting in November, are radiofrequency wireless devices designed to treat patients with heart failure and heart arrhythmias.

Related Summaries